Checkpoint inhibitors are a basic science-based, transformative new treatment for lung cancer
Author(s)
Miller, AR;
Details
Publication Year 2023-02,Volume 28,Issue #2,Page 101-106
Journal Title
Respirology
Publication Type
Commentary
Publisher
Wiley
Keywords
Humans; *Lung Neoplasms/drug therapy; *Carcinoma, Non-Small-Cell Lung/drug therapy; Immunotherapy; T cell biology; animal models; basic science; checkpoint inhibitors
Department(s)
Clinical Services
PubMed ID
36535890
Open Access at Publisher's Site
https://doi.org/10.1111/resp.14437
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-06-06 06:44:08
Last Modified: 2023-06-06 06:45:18
An error has occurred. This application may no longer respond until reloaded. Reload 🗙